Whilst p11 is a potential source of new therapies, unfortunately at the moment we do not know enough about p11 to target it selectively with drugs.

However, p11 is functionally linked to a serotonin receptor, and there are a number of drugs in development that act selectively on this receptor, and some of these drugs show antidepressant potential in laboratory models. We will know in a few years whether these kinds of drugs are better than the antidepressant treatments that we already have.